The first BSPHO Scientific Meeting of 2025 will be held on 21 February, from 16:00 to 18:30, at the BSPHO office, Brussels. The meeting is organized by UZA.
This meeting provides a valuable opportunity to connect, exchange knowledge, and discuss recent advancements in pediatric hematology and oncology.
This is an open meeting so don’t hesitate to share the invite with your colleagues.
Event is free of charge but registration is mandatory.
Time | Topic | Speaker |
16:00 | Gross tumor volume increase and need for adaptive radiotherapy in pediatric-type diffuse high-grade glioma of the midline structures | Dr. Toon Van Genechten |
16:30 | Prestin as biomarker for ototoxicity in pediatric oncology | Dr. PhD Jaques Van Heerden |
17:00 | CAR-NK therapy: promising future therapy for childhood cancer? | Dr. Liesbeth Vanheeswijck |
17:30 | A 69 long noncoding RNA signature predicts relapse and acts as independent prognostic factor in pediatric AML | Zhiyao Ren |
18:00 | Networking Drink |
Accreditation points are requested.
Location : BSPHO office (BLSI - 6th floor) 30, Clos Chapelle-aux-Champs - 1200 Brussel
How to get there: (check for details here)
Check out the highlights and photos from our last BSPHO meeting here.
This Scientific meeting is sponsored by the Olivia Fund.
The Olivia Fund supports multiple innovative research projects in the field of paediatric cancer in order to improve the outcome and care of paediatric cancer patients. Any contribution can be of much value.
Want to find out more about the Olivia Fund? Check the website: www.olivia.be